Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

So I wrote again: How can Kevetrin move forward with phase 2 studies when safety with more frequent dosing has not been established?

For those of you with better access to Leo pls see if you can get an answer to this question.

Maybe the answer is, phase 2 studies start all of the time without precise knowledge of side effects at the doses used. If it is that simple, fine by me, still a concern for safety profile for Kevetrin